Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysis.

Breast · 2025 · PMC12495238 · PMID 40991980

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Moreover, we observed a clear trend of increasing PIK3CA mutation rates with HER2 IHC scores.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.